Identifying disease risks early is a key to preventative healthcare. HealthIQ is an innovative product line that provides comprehensive understanding of chronic disease risks. It includes risk scores for multiple chronic conditions, commonly used blood markers and unique insights to special lipids, nutrition and systemic inflammation. HealthIQ intuitive disease risk scores require only age and sex as clinical inputs, saving healthcare professionals valuable time and enabling a more holistic and preventative approach to patient care.

The technology behind HealthIQ’s risk scores and unique blood markers, developed by Nightingale Health, provides scientifically scrutinized insights to understand chronic diseases. With over 600 peer-reviewed publications in leading biomedical journals
and regulatory approvals for clinical use, the technology offers an unparalleled level of validation and confidence for clinical application. The tests utilizing Nightingale Health’s technology are conducted in Innoquest Diagnostics’s ISO 15189- and CAPaccredited
laboratory and are approved by the HSA.

HealthIQ integrates unique strengths of Nightingale Health and Innoquest Diagnostics to empower clinicians with smarter disease risk assessment to drive early disease risk detection and transformative prevention.